2016 ESMO Copenhagen

Berit Eberhardt represented IKCC at the European Society for Medical Oncology conference in Copenhagen, October 2016.

The theme of our booth was “An apple a day … keeps the doctor supporting patients with kidney cancer!”

The booth was very busy!  Berit explained our current and planned projects, and chatted with visitors about clinical trials, 10 for IO, and our growing number of Affiliate groups worldwide.

IKCC Conference, 6th – 8th April 2017, Warsaw, Poland

7th International Kidney Cancer Coalition Conference

Warsaw, Poland 6th, 7th & 8th April 2017

 Our seventh IKCC Conference for kidney cancer patient organisations will be held in Warsaw, Poland on 6th, 7th & 8th April 2017.

Our conference will bring together cancer patient group leaders from around the world to share best practices, exchange experiences and work together to improve the lives of kidney cancer patients wherever they live. Read more

The main goals of our conference will

read more

IKCC voice on the NCI Renal Task Force

As of December 2016, there are now TWO patient advocates on the NCI Renal Task Force.

The US National Cancer Institute’s Renal Task Force is an advisory group that involves the renal oncology community to address the design and prioritization of NCI funded phase 2 and phase 3 clinical trials in renal cell cancer.

Deb Maskens joins the Task Force as a Patient Advocate from the IKCC (International Kidney

read more

KCCure to award large research grant

by Susan Poteat and Hans Hammers, M.D.

KCCure is pleased to announce an inaugural Request for Applications for a $100,000 Grant Award to fund innovative high-risk, high-impact ideas for kidney cancer research.  The application deadline is March 15, 2017.  The grant will be awarded in April 2017, and funding will cover a research project for a two year period.  Investigators representing academic research centers within the United States are eligible to apply.

Proposed projects should develop

read more